The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

H. H. Nerild; A. Bronden; A. E. Haddouchi; J. J. Holst; D. P. Sonne; T. Vilsboll; F. K. Knop

doi:10.1007/s00125-021-05519-y

The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

H. H. Nerild
, A. Bronden
, A. E. Haddouchi
, J. J. Holst
, D. P. Sonne
, T. Vilsboll
, F. K. Knop

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Originalsprog	Engelsk
Artikelnummer	422
Tidsskrift	Diabetologia
Vol/bind	64
Udgave nummer	SUPPL 1
Sider (fra-til)	217-217
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-021-05519-y
Status	Udgivet - 2021

Finansiering

The study was supported by Sanofi

Adgang til dokumentet

10.1007/s00125-021-05519-yLicens: Ikke-specificeret

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

@article{dfa853a57735455fb0f457213ee0f550,

title = "The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1",

author = "Nerild, \{H. H.\} and A. Bronden and Haddouchi, \{A. E.\} and Holst, \{J. J.\} and Sonne, \{D. P.\} and T. Vilsboll and Knop, \{F. K.\}",

year = "2021",

doi = "10.1007/s00125-021-05519-y",

language = "English",

volume = "64",

pages = "217--217",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "SUPPL 1",

}

TY - ABST

T1 - The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

AU - Nerild, H. H.

AU - Bronden, A.

AU - Haddouchi, A. E.

AU - Holst, J. J.

AU - Sonne, D. P.

AU - Vilsboll, T.

AU - Knop, F. K.

PY - 2021

Y1 - 2021

U2 - 10.1007/s00125-021-05519-y

DO - 10.1007/s00125-021-05519-y

M3 - Conference abstract in journal

C2 - 34468792

SN - 0012-186X

VL - 64

SP - 217

EP - 217

JO - Diabetologia

JF - Diabetologia

IS - SUPPL 1

M1 - 422

ER -